Tyrosine kinase inhibitor dasatinib specifically induces apoptosis in EB virus-infected gastric epithelial cells

被引:0
|
作者
Liu, Yuxin [1 ]
Iizasa, Hisashi [1 ]
Aungphyo, Wai [1 ]
Fatimah, Afifah [1 ]
Khatun, Mstmahmuda [1 ]
Thinmyat, Moe [1 ]
Okada, Shunpei [1 ]
Yoshiyama, Hironori [1 ]
机构
[1] Shimane Univ, Fact Med, Dept Micro, Matsue, Shimane, Japan
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P-1026
引用
收藏
页码:510 / 510
页数:1
相关论文
共 50 条
  • [21] The tyrosine kinase inhibitor STI571 induces cellular clearance of PrPSc in prion-infected cells
    Ertmer, A
    Gilch, S
    Yun, SW
    Flechsig, E
    Klebl, B
    Stein-Gerlach, M
    Klein, MA
    Schätzl, HM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (40) : 41918 - 41927
  • [22] Induction of Apoptosis and Subsequent Phagocytosis of Virus-Infected Cells As an Antiviral Mechanism
    Nainu, Firzan
    Shiratsuchi, Akiko
    Nakanishi, Yoshinobu
    FRONTIERS IN IMMUNOLOGY, 2017, 8
  • [23] Induction of IL-8 by Cryptosporidium parvum infected epithelial cells is inhibited by tyrosine kinase inhibitor genestein
    Pollok, RCG
    Gyselman, VG
    Bustin, SA
    McKay, IA
    Onwuegbusi, B
    Kelly, MP
    McDonald, V
    Farthing, MJG
    GASTROENTEROLOGY, 1999, 116 (04) : A712 - A713
  • [24] DEOXYTHYMIDYLATE SYNTHETASE AND DEOXYTHYMIDINE KINASE ACTIVITIES OF VIRUS-INFECTED ANIMAL CELLS
    FREARSON, PM
    KIT, S
    DUBBS, DR
    CANCER RESEARCH, 1965, 25 (5P1) : 737 - &
  • [25] Lenalidomide Effectively Induces Philadelphia-Chromosome Positive ALL Cells into Apoptosis in Synergy with Tyrosine Kinase Inhibitor
    Harama, Daisuke
    Tamai, Minori
    Inukai, Takeshi
    Goi, Kumiko
    Yahata, Takashi
    Ando, Kiyoshi
    Ito, Takumi
    Handa, Hiroshi
    Sugita, Kanji
    BLOOD, 2016, 128 (22)
  • [26] Alisertib, an Aurora kinase A inhibitor, induces apoptosis and autophagy but inhibits epithelial to mesenchymal transition in human epithelial ovarian cancer cells
    Ding, Yong-Hui
    Zhou, Zhi-Wei
    Ha, Chun-Fang
    Zhang, Xue-Yu
    Pan, Shu-Ting
    He, Zhi-Xu
    Edelman, Jeffrey L.
    Wang, Dong
    Yang, Yin-Xue
    Zhang, Xueji
    Duan, Wei
    Yang, Tianxin
    Qiu, Jia-Xuan
    Zhou, Shu-Feng
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2015, 9 : 425 - 464
  • [27] Clonal expansion of T/NK-cells during tyrosine kinase inhibitor dasatinib therapy
    Mustjoki, S.
    Ekblom, M.
    Arstila, T. P.
    Dybedal, I.
    Epling-Burnette, P. K.
    Guilhot, F.
    Hjorth-Hansen, H.
    Hoglund, M.
    Kovanen, P.
    Laurinolli, T.
    Liesveld, J.
    Paquette, R.
    Pinilla-Ibarz, J.
    Rauhala, A.
    Shah, N.
    Simonsson, B.
    Sinisalo, M.
    Steegmann, J. L.
    Stenke, L.
    Porkka, K.
    LEUKEMIA, 2009, 23 (08) : 1398 - 1405
  • [28] Clonal Expansion of T/NK-Cells during Tyrosine Kinase Inhibitor Dasatinib Therapy
    Mustjoki, Satu
    Ekblom, Marja
    Arstila, T. Petteri
    Dybedal, Ingunn
    Epling-Burnette, P. K.
    Garzon, Felix
    Gedde-Dahl, Tobias
    Hernesniemi, Sari
    Hjorth-Hansen, Henrik
    Hoglund, Martin
    Juvonen, Vesa
    Kairisto, Veli
    Kovanen, Panu
    Kreutzman, Anna
    Laurinolli, Tuisku
    Liesveld, Jane
    Paquette, Ronald
    Pinilla, Javier
    Rauhala, Auvo
    Shah, Neil
    Simonsson, Bengt
    Sinisalo, Marjatta
    Luis Steegmann, Juan
    Stenke, Leif
    Vakkila, Jukka
    Porkka, Kimmo
    BLOOD, 2008, 112 (11) : 215 - 215
  • [29] Effect of the SRC tyrosine kinase inhibitor dasatinib in combination with erlotinib and in cells with acquired resistance to erlotinib
    Haura, E.
    Gao, J.
    Li, J.
    EJC SUPPLEMENTS, 2006, 4 (12): : 182 - 182
  • [30] Clonal expansion of T/NK-cells during tyrosine kinase inhibitor dasatinib therapy
    S Mustjoki
    M Ekblom
    T P Arstila
    I Dybedal
    P K Epling-Burnette
    F Guilhot
    H Hjorth-Hansen
    M Höglund
    P Kovanen
    T Laurinolli
    J Liesveld
    R Paquette
    J Pinilla-Ibarz
    A Rauhala
    N Shah
    B Simonsson
    M Sinisalo
    J L Steegmann
    L Stenke
    K Porkka
    Leukemia, 2009, 23 : 1398 - 1405